Clovis Oncology, Inc. (CLVS) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 10/20/2018 1 month $26.36 $16.49 -37.44% 37 Ended
Comments: High Risk. Speculation. Stock Overpriced
Sepehr Kousha Sepehr Kousha 05/04/2017 3 months $50.10 $81.86 +63.41% -63 Ended
Comments: Way past its support at 50s
laurvp laurvp 09/11/2015 1 month $104.26 $93.60 -10.22% 10 Ended
beginner rater beginner rater 07/10/2015 1 week $80.39 $87.37 +8.68% 8 Ended
Comments: Bump to 90 following supplementary offering
LovingGeneva LovingGeneva 04/13/2015 3 months $86.12 $80.02 -7.08% -7 Ended
Comments: GS target 50% upside $117, Roci sales up, front line to market shows differentiation
InvestorsXpress InvestorsXpress 06/03/2013 1 day $36.58 $73.91 +102.05% 102 Ended
JOKER66 JOKER66 11/12/2012 1 day $21.49 $12.85 -40.2% 40 Ended

Neither NASDAQ, Inc. nor any of its affiliates (collectively "NASDAQ") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ. Investors should undertake their own due diligence and carefully evaluate companies before investing.